InsidersTradesSigma
삼천당제약: management transactions · South Korea · DART (FSS)
DART:company-1f3f95KR·DART (FSS)Mcap 5407.5Bn€
Browse the full directors' dealings record of 삼천당제약, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Market capitalisation: €5,407.5bn. The latest transaction was filed on 6 April 2026 (Mixed). Among the most active insiders: 전인석. The full history is accessible without an account.
2
Insider Decl.
0
Thresholds
·
0 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
373500.00 €
Income statement
Revenue231.81 Bn€
Gross profit109.38 Bn€47% margin
Net income5.26 Bn€2.3% margin
Balance sheet & cash
Market cap5407.46 Bn€
Total debt69.83 Bn€
Free Cash Flow−49.79 Bn€
Last declaration on 6 April 2026